267 related articles for article (PubMed ID: 26055448)
21. Direct and Indirect Effects on Viral Translation and RNA Replication Are Required for AUF1 Restriction of Enterovirus Infections in Human Cells.
Ullmer W; Semler BL
mBio; 2018 Sep; 9(5):. PubMed ID: 30181254
[TBL] [Abstract][Full Text] [Related]
22. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.
Luo H; Yanagawa B; Zhang J; Luo Z; Zhang M; Esfandiarei M; Carthy C; Wilson JE; Yang D; McManus BM
J Virol; 2002 Apr; 76(7):3365-73. PubMed ID: 11884562
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of glycogen synthase kinase 3beta suppresses coxsackievirus-induced cytopathic effect and apoptosis via stabilization of beta-catenin.
Yuan J; Zhang J; Wong BW; Si X; Wong J; Yang D; Luo H
Cell Death Differ; 2005 Aug; 12(8):1097-106. PubMed ID: 15905881
[TBL] [Abstract][Full Text] [Related]
24. The protective role of microRNA-21 against coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway.
He F; Xiao Z; Yao H; Li S; Feng M; Wang W; Liu Z; Liu Z; Wu J
J Transl Med; 2019 Oct; 17(1):335. PubMed ID: 31585536
[TBL] [Abstract][Full Text] [Related]
25. Cardiac miR-19a/19b was induced and hijacked by CVB3 to facilitate virus replication via targeting viral genomic RdRp-encoding region.
Wu Y; Yue Y; Xiong S
Antiviral Res; 2023 Sep; 217():105702. PubMed ID: 37604350
[TBL] [Abstract][Full Text] [Related]
26. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication.
Si X; Wang Y; Wong J; Zhang J; McManus BM; Luo H
J Virol; 2007 Apr; 81(7):3142-50. PubMed ID: 17229707
[TBL] [Abstract][Full Text] [Related]
27. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis.
Opavsky MA; Martino T; Rabinovitch M; Penninger J; Richardson C; Petric M; Trinidad C; Butcher L; Chan J; Liu PP
J Clin Invest; 2002 Jun; 109(12):1561-9. PubMed ID: 12070303
[TBL] [Abstract][Full Text] [Related]
28. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
[TBL] [Abstract][Full Text] [Related]
29. Activation of AMP-activated protein kinase reduces collagen production via p38 MAPK in cardiac fibroblasts induced by coxsackievirus B3.
Jiang S; Jiang D; Zhao P; He X; Tian S; Wu X; Tao Y
Mol Med Rep; 2016 Jul; 14(1):989-94. PubMed ID: 27221787
[TBL] [Abstract][Full Text] [Related]
30. Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response.
Dai Q; He X; Yu H; Bai Y; Jiang L; Sheng H; Peng J; Wang M; Yu J; Zhang K
J Med Virol; 2021 Jun; 93(6):3581-3589. PubMed ID: 33336842
[TBL] [Abstract][Full Text] [Related]
31. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
32. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
[TBL] [Abstract][Full Text] [Related]
33. In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell
Kraft L; Sauter M; Seebohm G; Klingel K
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578416
[TBL] [Abstract][Full Text] [Related]
34. Divergent Requirement for a DNA Repair Enzyme during Enterovirus Infections.
Maciejewski S; Nguyen JH; Gómez-Herreros F; Cortés-Ledesma F; Caldecott KW; Semler BL
mBio; 2015 Dec; 7(1):e01931-15. PubMed ID: 26715620
[TBL] [Abstract][Full Text] [Related]
35. The Nuclear Pore Complex 62 Suppression Inhibits Coxsackievirus B Replication and Inflammatory Response.
Liu T; Shi Y; Wang H; Shen H; Qu J
Viral Immunol; 2022 Jun; 35(5):381-385. PubMed ID: 35605096
[TBL] [Abstract][Full Text] [Related]
36. Green Tea Polyphenol Epigallocatechin-3-gallate-Alleviated Coxsackievirus B3-induced Myocarditis Through Inhibiting Viral Replication but Not Through Inhibiting Inflammatory Responses.
He X; Gao B; Zhou L; Xiong S
J Cardiovasc Pharmacol; 2017 Jan; 69(1):41-47. PubMed ID: 27753702
[TBL] [Abstract][Full Text] [Related]
37.
Fu Q; Gao L; Fu X; Meng Q; Lu Z
J Microbiol Biotechnol; 2019 Aug; 29(8):1230-1239. PubMed ID: 31370111
[No Abstract] [Full Text] [Related]
38. Histone deacetylase inhibitors suppress coxsackievirus B3 growth in vitro and myocarditis induced in mice.
Shim SH; Park JH; Ye MB; Nam JH
Acta Virol; 2013; 57(4):462-6. PubMed ID: 24294962
[TBL] [Abstract][Full Text] [Related]
39. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
40. [The suppressive effect of MiR-490 on coxsackievirus B3 replication].
Wang LL; Zhong ZH; Wang Q; Lu P; Li M; Xu HY
Bing Du Xue Bao; 2014 Nov; 30(6):619-23. PubMed ID: 25868275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
